Study discovered common mechanism that tumour exploit to inhibit immune responses
Ludwig Cancer Research team have found a single protein that is produced at high levels by cancer cells across a wide spectrum of malignancies. In animal models of cancer, this protein builds a complex barrier to anti-cancer immune responses, shielding tumo...
10 December, 2022
Read more